Foundation Medicine (FMI) Misses Q3 EPS by 2c

Foundation Medicine (NASDAQ: FMI) reported Q3 EPS of ($0.90), $0.02 worse than the analyst estimate of ($0.88). Revenue for the quarter came in at $29.4 million versus the consensus estimate of $28.7 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04